Recce Pharmaceuticals doses first cohort in RECCE 327 rapid infusion phase I/II UTI clinical trial

Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) has successfully dosed its first cohort of both male and female subjects with RECCE 327 (R327) as part of its...

Related Keywords

,Alanw Dunton ,Recce Pharmaceuticals Ltd ,